Zentera Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $75M

  • Investors
  • 12

Zentera Therapeutics General Information

Description

Manufacturer of small-molecule oncology therapeutics designed to address unmet medical needs in solid and hematologic cancers. The company offers clinical-stage drug candidates targeting cancer-related biological pathways, including therapies focused on WEE1, BCL-2, and estrogen receptor targets, enabling oncologists, cancer patients, and healthcare institutions to access precision treatment options with improved disease management potential.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 29th Floor, Block A, Phase III, Xujiahui Center
  • Number 183 Hongqiao Road, Xuhui District, Shanghai (Unit 2903-07)
  • Shanghai, 200011
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • 29th Floor, Block A, Phase III, Xujiahui Center
  • Number 183 Hongqiao Road, Xuhui District, Shanghai (Unit 2903-07)
  • Shanghai, 200011
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zentera Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 02-Aug-2021 $75M Completed Clinical Trials - General
2. Early Stage VC (Series A) 20-May-2020 Completed Clinical Trials - General
1. Joint Venture 15-May-2020 Completed Clinical Trials - General
To view Zentera Therapeutics’s complete valuation and funding history, request access »

Zentera Therapeutics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Avidity Partners Asset Manager Minority
Casdin Capital Venture Capital Minority
Farallon Capital Management Hedge Fund Minority
LAV (Lilly Asia Fund) Corporate Venture Capital Minority
Logos Capital Hedge Fund Minority
You’re viewing 5 of 12 investors. Get the full list »

Zentera Therapeutics Investments (1)

Zentera Therapeutics’s most recent deal was a Joint Venture with Zentera Alpha. The deal was made on 01-Jan-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Zentera Alpha 01-Jan-2022 Joint Venture Drug Discovery
To view Zentera Therapeutics’s complete investments history, request access »

Zentera Therapeutics FAQs

  • When was Zentera Therapeutics founded?

    Zentera Therapeutics was founded in 2020.

  • Where is Zentera Therapeutics headquartered?

    Zentera Therapeutics is headquartered in Shanghai, China.

  • What industry is Zentera Therapeutics in?

    Zentera Therapeutics’s primary industry is Drug Discovery.

  • Is Zentera Therapeutics a private or public company?

    Zentera Therapeutics is a Private company.

  • What is Zentera Therapeutics’s current revenue?

    The current revenue for Zentera Therapeutics is .

  • How much funding has Zentera Therapeutics raised over time?

    Zentera Therapeutics has raised $95M.

  • Who are Zentera Therapeutics’s investors?

    Avidity Partners, Casdin Capital, Farallon Capital Management, LAV (Lilly Asia Fund), and Logos Capital are 5 of 12 investors who have invested in Zentera Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process